Patent Assignment
Reel/Frame 055027/0606
Release of Security Interest
Recorded: 2021-01-26
Pages: 13
Assignor
OXFORD FINANCE LLC, AS COLLATERAL AGENT
Executed: 2021-01-21
Assignees
OXFORD BIOTHERAPEUTICS INC.
5941 OPTICAL COURT, SAN JOSE, CALIFORNIA, 95138
OXFORD BIOTHERAPEUTICS LTD.
94A INNOVATION DRIVE, MILTON PARK, ABINGDON, OXON, OX14 4RZ, UNITED KINGDOM
Covered Properties
(16)
Protein
Proteins
Fully Human Antibodies Specific to CADM1
Antibodies Specific to Cadherin-17
Anti-ROR1 Antibodies and Methods of Use for Treatment of Cancer
Antibodies
Therapeutic and Diagnostic Target
Identification of Protein Associated with Hepatocellular Carcinoma, Gliobastoma and Lung Cancer
Methods of Treating Acute Myeloid Leukemia with Antibodies to Bone Marrow Stromal Antigen 1
Conjugated Antibodies Against LY75 for the Treatment of Cancer
Nucleic Acid Encoding Bone Marrow Stromal Antigen 1 Antibody
Identification of Protein Associated with Hepatocellular Carcinoma, Gliobastoma and Lung Cancer
Application:
15/874,110 →
Publication:
US 2018/0246114
Conjugated Antibodies Against LY75 for the Treatment of Cancer
Application:
16/140,089 →
Publication:
US 2019/0106506
Antibodies to Bone Marrow Stromal Antigen 1
Proteins
Application:
16/385,570 →
Publication:
US 2019/0310255
LY75 as Cancer Therapeutic and Diagnostic Target
Application:
16/392,796 →
Publication:
US 2019/0317100
Related Assignments
(19)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest
Dec 28, 2009
From: ROHLFF, CHRISTIAN; STAMPS, ALASDAIR
To: OXFORD BIOTHERAPEUTICS LTD.
Reel/Frame 023710/0420 →
Assignment of Assignor's Interest
Dec 28, 2009
From: ROHLFF, CHRISTIAN; STAMPS, ALASDAIR
To: OXFORD BIOTHERAPEUTICS LTD.
Reel/Frame 023710/0459 →
Assignment of Assignor's Interest
Nov 7, 2011
From: ROHLFF, CHRISTIAN; TERRETT, JONATHAN ALEXANDER
To: OXFORD BIOTHERAPEUTICS LTD.
Reel/Frame 027187/0323 →
Assignment of Assignor's Interest
Nov 7, 2011
From: TERRETT, JONATHAN ALEXANDER; LEBLANC, HEIDI N.; HUANG, HAICHUN; MEADDOUGH, ERIKA
To: MEDAREX, INC.
Reel/Frame 027186/0107 →
Assignment of Assignor's Interest
Jan 14, 2013
From: MEDAREX, INC.
To: OXFORD BIOTHERAPEUTICS LTD
Reel/Frame 029623/0007 →
Assignment of Assignor's Interest
Mar 28, 2013
From: ROHLFF, CHRISTIAN; TERRETT, JONATHAN ALEXANDER
To: OXFORD BIOTHERAPEUTICS LTD
Reel/Frame 030104/0610 →
Assignment of Assignor's Interest
Jun 3, 2013
From: ROHLFF, CHRISTIAN; STAMPS, ALASDAIR; TERRETT, JONATHAN ALEXANDER
To: OXFORD BIOTHERAPEUTICS LTD.
Reel/Frame 030535/0927 →
Assignment of Assignor's Interest
Feb 25, 2014
From: ROHLFF, CHRISTIAN; STAMPS, ALASDAIR
To: OXFORD BIOTHERAPEUTICS LTD.
Reel/Frame 032295/0111 →
Merger
May 8, 2014
From: MEDAREX, INC.
To: MEDAREX, L.L.C.
Reel/Frame 032848/0038 →
Merger
Jun 3, 2015
From: MEDAREX, L.L.C.
To: E. R. SQUIBB & SONS, L.L.C.
Reel/Frame 035778/0686 →
Assignment of Assignor's Interest
Sep 25, 2015
From: ROHLFF, CHRISTIAN; TERRETT, JONATHAN ALEXANDER
To: OXFORD BIOTHERAPEUTICS LTD
Reel/Frame 036656/0322 →
Assignment of Assignor's Interest
Apr 6, 2016
From: ROHLFF, CHRISTIAN
To: OXFORD BIOTHERAPEUTICS LTD.
Reel/Frame 038202/0543 →
Assignment of Assignor's Interest
Aug 19, 2016
From: TERRETT, JONATHAN ALEXANDER; ACKROYD, JAMES EDWARD
To: OXFORD BIOTHERAPEUTICS LTD
Reel/Frame 039491/0358 →
Assignment of Assignor's Interest
Jul 11, 2017
From: ROHLFF, CHRISTIAN; TERRETT, JONATHAN ALEXANDER
To: OXFORD BIOTHERAPEUTICS LTD
Reel/Frame 042978/0570 →
Assignment of Assignor's Interest
Jan 18, 2018
From: ROHLFF, CHRISTIAN
To: OXFORD BIOTHERAPEUTICS LTD.
Reel/Frame 044653/0787 →
Assignment of Assignor's Interest
Feb 28, 2019
From: ROHLFF, CHRISTIAN; TERRETT, JONATHAN ALEXANDER
To: OXFORD BIOTHERAPEUTICS LTD.
Reel/Frame 048461/0463 →
Assignment of Assignor's Interest
Aug 23, 2019
From: PURFEY, KENNETH
To: IDS INTERNATIONAL BV
Reel/Frame 050152/0552 →
Security Interest
Aug 28, 2019
From: OXFORD BIOTHERAPEUTICS INC.; OXFORD BIOTHERAPEUTICS LTD.
To: OXFORD FINANCE LLC, AS COLLATERAL AGENT
Reel/Frame 050197/0172 →
Release of Security Interest
Jan 26, 2021
From: OXFORD FINANCE LLC, AS COLLATERAL AGENT
To: OXFORD BIOTHERAPEUTICS INC.
Reel/Frame 055026/0720 →